Ultra-sensitive tests bring biomarkers into the drug development forefront

Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. Revolutionary drugs often get the bulk of attention surrounding medical advances. But their success in the real world is intrinsically tied to the screening process that finds which patients would benefit. Quanterix CEO Masoud Toloue Permission granted … Read more